1
691 Piehler et al: Bronchogenic Carcinoma with Chest Wall Invasion neoplasms with survival of 236 patients from our in- stitution who had T2 NO stage I neoplasms and found the survival curves to be remarkably similar, with no statistical difference. We conclude that pa- tients with bronchogenic carcinoma invading the chest wall without lymph node metastasis represent a very favorable subset of patients and that con- tinued aggressive surgical management appears to be warranted. (For additional discussion of this article, see pp 696-697.) Notice from The American Board of Surgery The American Board of Surgery, Inc., an- nounces that it is now authorized to offer the Certification of Special Qualifications in Gen- eral Vascular Surgery to its Diplomates and to those of the American Board of Thoracic Surgery. It is not the intent of The American Board of Surgery to award this special certifi- cation to surgeons whose training or practice in vascular surgery is covered by the usual parameters of general and thoracic surgery. The certification is to be awarded only to those who have had intensive or additional approved training, or both, in this discipline, or who over a period of five years or more have clearly dem- onstrated their dedication to vascular surgery by making well-known and important con- tributions to the specialty. Certification will be offered on an annual basis. The first cycle of evaluation of surgeons who seek this special certification is now be- ginning, and the final step, a written examina- tion, will be completed on November 18, 1983. Interested surgeons who feel that they qualify should address their inquiries-as soon as pos- sible but no later than April 1, 1983-to the Sec- retary, The American Board of Surgery, Inc., 1617 John F. Kennedy Blvd, Philadelphia, PA 19103.

Notice from the American Board of Surgery, Inc

  • Upload
    magali

  • View
    213

  • Download
    1

Embed Size (px)

Citation preview

Page 1: Notice from the American Board of Surgery, Inc

691 Piehler et al: Bronchogenic Carcinoma with Chest Wall Invasion

neoplasms with survival of 236 patients from our in- stitution who had T2 NO stage I neoplasms and found the survival curves to be remarkably similar, with no statistical difference. We conclude that pa- tients with bronchogenic carcinoma invading the chest wall without lymph node metastasis represent

a very favorable subset of patients and that con- tinued aggressive surgical management appears to be warranted.

(For additional discussion of this article, see pp 696-697.)

Notice from The American Board of Surgery

The American Board of Surgery, Inc., an- nounces that it is now authorized to offer the Certification of Special Qualifications in Gen- eral Vascular Surgery to its Diplomates and to those of the American Board of Thoracic Surgery. It is not the intent of The American Board of Surgery to award this special certifi- cation to surgeons whose training or practice in vascular surgery is covered by the usual parameters of general and thoracic surgery. The certification is to be awarded only to those who have had intensive or additional approved training, or both, in this discipline, or who over a period of five years or more have clearly dem-

onstrated their dedication to vascular surgery by making well-known and important con- tributions to the specialty.

Certification will be offered on an annual basis. The first cycle of evaluation of surgeons who seek this special certification is now be- ginning, and the final step, a written examina- tion, will be completed on November 18, 1983.

Interested surgeons who feel that they qualify should address their inquiries-as soon as pos- sible but no later than April 1, 1983-to the Sec- retary, The American Board of Surgery, Inc., 1617 John F. Kennedy Blvd, Philadelphia, PA 19103.